Daunorubicin hydrochloride is an anthracycline antineoplastic agent used in chemotherapy regimens for conditions such as acute myeloid leukemia and osteosarcoma. By intercalating into DNA and inhibiting… Read more

![Chemical structure of (8S,10S)-6,8,11-Trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-10-(((1S,3R,4aS,9S,9aR,10aS)-9-methoxy-1-methyloctahydro-1H-pyrano[4',3':4,5]oxazolo[2,3-c][1,4]oxazin-3-yl)oxy)-7,8,9,10-tetrahydrotetracene-5,12-dione](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F202350-68-3-8S10S-6811-Trihydroxy-8-2-hydroxyacetyl-1-methoxy-10-1S3R4aS9S9aR10aS-9-methoxy-1-methyloctahydro-1H-pyrano4345oxazolo23-c14oxazin-3-yloxy.png&w=3840&q=75)
Daunorubicin hydrochloride is an anthracycline antineoplastic agent used in chemotherapy regimens for conditions such as acute myeloid leukemia and osteosarcoma. By intercalating into DNA and inhibiting topoisomerase II, this drug effectively blocks macromolecular synthesis and induces apoptosis in rapidly dividing cancer cells. To support rigorous pharmaceutical quality control and method validation, researchers require high-quality reference standards that encompass the active ingredient, specific metabolites, and related impurities. Analytical laboratories utilize these materials, including stable isotope labelled compounds and pharmacopeial impurities, for accurate impurity profiling and to monitor chemical stability throughout the development and manufacturing process. This collection provides essential, precise tools for maintaining regulatory compliance and ensuring the integrity of analytical methods developed for this potent chemotherapy agent.
